Michael S. Weiss
TG Therapeutics
Chief Executive Officer and President
Overview
Michael S. Weiss received an average compensation of $8,250,210 at TG Therapeutics from 2011 to 2017.
Annual data
2017
| Non-Equity Incentive Plan | $217,969 |
|---|---|
| Salary | $525,000 |
| Stock Awards | $9,183,647 |
| Total | $9,926,616 |
In 2017, Michael S. Weiss earned a total compensation of $9,926,616 as Chief Executive Officer and President at TG Therapeutics.
Weiss received $9,183,647 in stock awards, which accounts for 92.52% of total compensation.
Weiss also received $217,969 in non-equity incentive plan and $525,000 in salary.
2016
| Non-Equity Incentive Plan | $276,000 |
|---|---|
| Salary | $375,000 |
| Stock Awards | $3,225,935 |
| Total | $3,876,935 |
In 2016, Michael S. Weiss earned a total compensation of $3,876,935 as Chief Executive Officer and President at TG Therapeutics.
Weiss received $3,225,935 in stock awards, which accounts for 83.21% of total compensation.
Weiss also received $276,000 in non-equity incentive plan and $375,000 in salary.
2015
| Non-Equity Incentive Plan | $203,125 |
|---|---|
| Salary | $325,000 |
| Stock Awards | $13,440,772 |
| Total | $13,968,897 |
In 2015, Michael S. Weiss earned a total compensation of $13,968,897 as Chief Executive Officer and President at TG Therapeutics.
Weiss received $13,440,772 in stock awards, which accounts for 96.22% of total compensation.
Weiss also received $203,125 in non-equity incentive plan and $325,000 in salary.
2012
| Salary | $225,000 |
|---|---|
| Stock Awards | $11,003,601 |
| Total | $11,228,601 |
In 2012, Michael S. Weiss earned a total compensation of $11,228,601 as Executive Chairman, Interim Chief Executive Officer and President at TG Therapeutics.
Weiss received $11,003,601 in stock awards, which accounts for 98.00% of total compensation.
Weiss also received $225,000 in salary.
2011
| Stock Awards | $2,250,000 |
|---|---|
| Total | $2,250,000 |
In 2011, Michael S. Weiss earned a total compensation of $2,250,000 as Executive Chairman, Interim Chief Executive Officer and President at TG Therapeutics.
Weiss received $2,250,000 in stock awards, which accounts for 100.00% of total compensation.
Fortress Biotech
Executive Vice Chairman, Strategic Development
Overview
Michael S. Weiss received an average compensation of $5,277,307 at Fortress Biotech from 2014 to 2016.
Annual data
2016
| Non-Equity Incentive Plan | $500,000 |
|---|---|
| Salary | $29,689 |
| Stock Awards | $1,492,285 |
| Other | $72,015 |
| Total | $2,093,989 |
In 2016, Michael S. Weiss earned a total compensation of $2,093,989 as Executive Vice Chairman, Strategic Development at Fortress Biotech.
Weiss received $1,492,285 in stock awards, which accounts for 71.27% of total compensation.
Weiss also received $500,000 in non-equity incentive plan, $29,689 in salary and $72,015 in other compensation.
2015
| Non-Equity Incentive Plan | $500,000 |
|---|---|
| Salary | $28,275 |
| Stock Awards | $1,424,111 |
| Other | $1,114,341 |
| Total | $3,066,727 |
In 2015, Michael S. Weiss earned a total compensation of $3,066,727 as Executive Vice Chairman, Strategic Development at Fortress Biotech.
Weiss received $1,424,111 in stock awards, which accounts for 46.44% of total compensation.
Weiss also received $500,000 in non-equity incentive plan, $28,275 in salary and $1,114,341 in other compensation.
2014
| Salary | $24,324 |
|---|---|
| Stock Awards | $10,646,881 |
| Total | $10,671,205 |
In 2014, Michael S. Weiss earned a total compensation of $10,671,205 as Executive Vice Chairman, Strategic Development at Fortress Biotech.
Weiss received $10,646,881 in stock awards, which accounts for 99.77% of total compensation.
Weiss also received $24,324 in salary.
Keryx Biopharmaceuticals
Former Chairman and Chief Executive Officer
Overview
Michael S. Weiss received an average compensation of $4,302,891 at Keryx Biopharmaceuticals from 2006 to 2009.
Annual data
2009
| Option Awards | $263,585 |
|---|---|
| Salary | $273,085 |
| Stock Awards | $396,000 |
| Other | $666,705 |
| Total | $1,599,375 |
In 2009, Michael S. Weiss earned a total compensation of $1,599,375 as Former Chairman and Chief Executive Officer at Keryx Biopharmaceuticals.
Weiss received $666,705 in other compensation, which accounts for 41.69% of total compensation.
Weiss also received $263,585 in option awards, $273,085 in salary and $396,000 in stock awards.
2008
| Non-Equity Incentive Plan | $368,900 |
|---|---|
| Salary | $434,000 |
| Stock Awards | $378,000 |
| Total | $1,180,900 |
In 2008, Michael S. Weiss earned a total compensation of $1,180,900 as Former Chairman and Chief Executive Officer at Keryx Biopharmaceuticals.
Weiss received $434,000 in salary, which accounts for 36.75% of total compensation.
Weiss also received $368,900 in non-equity incentive plan and $378,000 in stock awards.
2007
| Non-Equity Incentive Plan | $206,310 |
|---|---|
| Option Awards | $5,061,674 |
| Salary | $390,000 |
| Total | $5,657,984 |
In 2007, Michael S. Weiss earned a total compensation of $5,657,984 as Chairman and Chief Executive Officer at Keryx Biopharmaceuticals.
Weiss received $5,061,674 in option awards, which accounts for 89.46% of total compensation.
Weiss also received $206,310 in non-equity incentive plan and $390,000 in salary.
2006
| Non-Equity Incentive Plan | $2,292,500 |
|---|---|
| Option Awards | $6,100,980 |
| Salary | $375,000 |
| Other | $4,824 |
| Total | $8,773,304 |
In 2006, Michael S. Weiss earned a total compensation of $8,773,304 as Chairman and Chief Executive Officer at Keryx Biopharmaceuticals.
Weiss received $6,100,980 in option awards, which accounts for 69.54% of total compensation.
Weiss also received $2,292,500 in non-equity incentive plan, $375,000 in salary and $4,824 in other compensation.